Aparito worked with teams at the University of Cambridge and the University of Liverpool to deliver the HEAL-COVID study to test a number of safe, existing drugs on patients across the UK to find effective treatments and reduce the number of people who die in the months following a stay in hospital with COVID-19.
21 CFR Part 11 compliant
Cyber Essentials Plus
Would you like to partner with us? Contact us using the form below.